Measles virus (strain Edmonston-AIK-C vaccine) Hemagglutinin glycoprotein 250-259, SMYRVFEVGV
Description
About Measles virus (strain Edmonston-AIK-C vaccine) Hemagglutinin glycoprotein 250-259, SMYRVFEVGV
The Measles virus (strain Edmonston-AIK-C vaccine) Hemagglutinin glycoprotein glycoprotein Peptide (IEDB: 59787) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Hemagglutinin glycoprotein Peptide, H-SMYRVFEVGV-OH (Uniprot: P35971 aa: 250-259) from JPT is produced under strict quality control and quality management.
Measles virus (strain Edmonston-AIK-C vaccine) Hemagglutinin glycoprotein 250-259, SMYRVFEVGV - Specifications
- Peptide sequence: H-SMYRVFEVGV-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Measles
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Measles virus (strain Edmonston-AIK-C vaccine) Hemagglutinin glycoprotein 250-259, SMYRVFEVGV
References:
Read References with JPT’s Antigen Peptides
Measles virus (strain Edmonston-AIK-C vaccine) Hemagglutinin glycoprotein 250-259, SMYRVFEVGV has been described in:
Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus., Virology, 2006 (PMID: 16781760)
Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination., J Infect Dis, 2007 (PMID: 17492596)
A library of cancer testis specific T cell receptors for T cell receptor gene therapy., Mol Ther Oncolytics, 2023 (PMID: 36589698)
Documentation
Documentation for Measles virus (strain Edmonston-AIK-C vaccine) Hemagglutinin glycoprotein 250-259, SMYRVFEVGV
Properties
Properties of Measles virus (strain Edmonston-AIK-C vaccine) Hemagglutinin glycoprotein 250-259, SMYRVFEVGV
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Measles |
Layout: | Freeze-dried in glass vial |
Organism: | Measles virus |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Measles virus (strain Edmonston-AIK-C vaccine) Hemagglutinin glycoprotein 250-259, SMYRVFEVGV
Information | Values |
---|---|
Sequence: | H-SMYRVFEVGV-OH |
Specifications: | 10mer peptide as TFA salt |